A detailed history of Sapience Investments, LLC transactions in Avid Bioservices, Inc. stock. As of the latest transaction made, Sapience Investments, LLC holds 201,880 shares of CDMO stock, worth $2.45 Million. This represents 1.25% of its overall portfolio holdings.

Number of Shares
201,880
Previous 202,470 0.29%
Holding current value
$2.45 Million
Previous $1.45 Million 58.96%
% of portfolio
1.25%
Previous 0.78%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$6.7 - $12.45 $3,953 - $7,345
-590 Reduced 0.29%
201,880 $2.3 Million
Q2 2024

Aug 14, 2024

BUY
$6.34 - $9.28 $1.28 Million - $1.88 Million
202,470 New
202,470 $1.45 Million

Others Institutions Holding CDMO

About Avid Bioservices, Inc.


  • Ticker CDMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,167,500
  • Market Cap $756M
  • Description
  • Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...
More about CDMO
Track This Portfolio

Track Sapience Investments, LLC Portfolio

Follow Sapience Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sapience Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sapience Investments, LLC with notifications on news.